HealthStream, Inc. (NASDAQ:HSTM - Free Report) - Investment analysts at Barrington Research upped their FY2024 earnings per share estimates for HealthStream in a research report issued on Wednesday, October 23rd. Barrington Research analyst V. Colicchio now expects that the technology company will post earnings of $0.62 per share for the year, up from their previous estimate of $0.58. The consensus estimate for HealthStream's current full-year earnings is $0.56 per share. Barrington Research also issued estimates for HealthStream's Q4 2024 earnings at $0.13 EPS and FY2025 earnings at $0.67 EPS.
HealthStream (NASDAQ:HSTM - Get Free Report) last issued its quarterly earnings data on Monday, October 21st. The technology company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.13 by $0.06. The business had revenue of $73.10 million during the quarter, compared to the consensus estimate of $73.53 million. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. The firm's revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.13 EPS.
A number of other equities analysts have also recently issued reports on HSTM. Barclays upped their target price on HealthStream from $32.00 to $34.00 and gave the stock an "overweight" rating in a report on Wednesday. Craig Hallum upgraded shares of HealthStream to a "strong-buy" rating in a report on Thursday, October 17th. Canaccord Genuity Group boosted their target price on shares of HealthStream from $28.00 to $29.00 and gave the stock a "hold" rating in a report on Wednesday. Finally, StockNews.com downgraded shares of HealthStream from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, July 24th. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $31.50.
Read Our Latest Report on HealthStream
HealthStream Stock Performance
Shares of HSTM traded up $0.20 during trading hours on Friday, reaching $28.31. The stock had a trading volume of 102,429 shares, compared to its average volume of 113,760. HealthStream has a 12 month low of $23.92 and a 12 month high of $31.15. The stock has a market capitalization of $860.57 million, a PE ratio of 48.81, a PEG ratio of 4.25 and a beta of 0.36. The company's 50-day moving average is $28.72 and its two-hundred day moving average is $27.91.
Hedge Funds Weigh In On HealthStream
Several institutional investors have recently made changes to their positions in HSTM. GAMMA Investing LLC raised its position in shares of HealthStream by 172.1% during the second quarter. GAMMA Investing LLC now owns 996 shares of the technology company's stock worth $28,000 after purchasing an additional 630 shares during the period. Point72 DIFC Ltd acquired a new position in HealthStream during the second quarter worth $38,000. Copeland Capital Management LLC acquired a new position in HealthStream during the third quarter worth $63,000. CWM LLC lifted its stake in shares of HealthStream by 405.4% in the second quarter. CWM LLC now owns 2,709 shares of the technology company's stock valued at $76,000 after buying an additional 2,173 shares in the last quarter. Finally, Diversified Trust Co acquired a new position in shares of HealthStream during the first quarter valued at about $213,000. Institutional investors and hedge funds own 69.58% of the company's stock.
Insider Activity
In other news, SVP Kevin P. O'hara sold 3,000 shares of HealthStream stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the transaction, the senior vice president now directly owns 9,527 shares of the company's stock, valued at approximately $267,041.81. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Tate Deborah Taylor sold 1,400 shares of the business's stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total transaction of $39,942.00. Following the transaction, the director now owns 22,326 shares in the company, valued at $636,960.78. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kevin P. O'hara sold 3,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total transaction of $84,090.00. Following the transaction, the senior vice president now directly owns 9,527 shares in the company, valued at approximately $267,041.81. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 20.60% of the company's stock.
HealthStream Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a $0.028 dividend. The ex-dividend date is Monday, November 4th. This represents a $0.11 dividend on an annualized basis and a dividend yield of 0.40%. HealthStream's dividend payout ratio (DPR) is currently 18.97%.
HealthStream Company Profile
(
Get Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Featured Articles
Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.